On March 11, 2020, the World Health Organization declared coronavirus disease 2019 (COVID-19) a pandemic. As of May 11, 2020, 4 006 257 people have been infected and 278 892 people have died worldwide.1 As cases of COVID-19 spread globally, so did sharing of experiences and research via social media in efforts to mitigate the disease spread and to increase awareness. Of note, the first warning came from an ophthalmologist, Dr. Li Wenliang, who had attempted to inform his colleagues via the social media platform WeChat and subsequently on Weibo (a Chinese microblogging website) about a suspected outbreak of severe acute respiratory disease-like illness.2 , 3 A coordinated global response has been important since to enable preparedness among healthcare workers, especially because healthcare workers are thought to be affected disproportionately during the pandemic. Specific to ophthalmology, concern has emerged that eye care providers are at a higher risk of contracting COVID-19 because of their close working proximity during an ophthalmic examination.4 , 5 With this perspective, we outline how social media increasingly has become integrated into our emergency response as a field.
Rapid Dissemination of Information on Social Media
In the early 2000s, when the severe acute respiratory syndrome outbreak affected China, Hong Kong, and Canada, before widespread use of social media networks, text and instant messaging were used primarily for rapid communication. Now with more than 2.9 billion users worldwide,6 social media, with its constant accessibility, has transformed how we communicate. Compared with more traditional methods of communication, such as television or print media, social media allows for instant dissemination of accurate information, which has been critical in alerting both the public and healthcare sectors to evolving guidelines and treatments.7
Although many social media platforms exist, Twitter, in particular, has been used widely by physicians.8 , 9 This microblogging platform allows authors to make short posts with up to 280 characters, along with an image or a link to another website. In the first quarter of 2020, Twitter reported that its average daily users had increased by 24% over the previous year to 166 million daily users, attributing much of that increase to activity resulting from the COVID-19 pandemic.10 The American Academy of Ophthalmology (AAO) Ophthalmology journal Twitter account (https://twitter.com/AAOjournal) shares recently published articles and the AAO’s account (https://twitter.com/aao_ophth) also posts regular updates for its members and the general public. By sharing recently published peer-reviewed articles online and alerting Twitter followers to these new updates, users can access research and new information much faster than with traditional print methods. As of May 1, 2020, Ophthalmology’s growing collection of COVID-19–related research articles and commentaries totaled more than 58 059 impressions on Twitter (mean impressions per post, 6451; range, 1626–18 216). When users like, comment, or retweet a post, it also can increase the original post’s impressions. Users on Twitter can amplify a post further by making a comment while retweeting another user’s post. These new posts additionally generate their own set of impressions, which are not counted in the original post’s impressions, thereby increasing visibility. For example, when totalling the impressions across the Twitter accounts of the 5 Ophthalmology social media editors (E.T., A.R.C., L.M.P., M.T.F., R.C.R.), the resulting total impressions for the same COVID-19 collection was 63 115 (mean impressions per post, 3005; range, 1252–8684). Thus, the visibility of posts shared on Twitter may be more far reaching than the 27 000 copies of Ophthalmology currently in print circulation. Additionally, because the number of practicing ophthalmologists in the United States is approximately 17 600,11 these posts are likely being viewed by ophthalmologists worldwide as well as healthcare professionals in other fields, which depends largely on each user’s followers.
Increasing Collaboration and Research
Social media and the Internet also have accelerated the creation of research networks and collaborations. In a global collaboration with ophthalmologists from Australia, China, Italy, Korea, Singapore, the United Kingdom, and the United States, Olivia Li et al7 reported global variations in risk mitigation for asymptomatic patients with COVID-19, with institutions around the world reporting varying uses of personal protective equipment in the clinical setting. In the era of COVID-19, as an alternative to scheduling in-person consensus meetings or online meetings over many different time zones, potential exists for working groups to be created via social media and for these groups to generate questions for guidelines. Radiation oncologists have used Twitter to create guidelines on prioritizing patient treatments during the pandemic as well as how to reduce the risk of transmission in the clinic.12 Also initiated through Twitter, rheumatologists have created a global registry of patients with rheumatic disease to evaluate the effects of pre-existing immunosuppression and outcomes of COVID-19 in this population.13 Gastroenterologists also were surveyed on Twitter regarding what constituted urgent endoscopy during the COVID-19 pandemic to help guide triage further.14 Similarly, ophthalmologists around the world have shared their responses and changes in clinical practices to decrease the risk to patients and physicians.7 , 15 Within other subspecialties of ophthalmology, patient care recommendations have been developed rapidly from groups such as the American Association of Ophthalmic Oncologists and Pathologists16 and the American Society of Retina Specialists.17 Social media groups on Facebook also have provided a means for healthcare workers around the world to communicate quickly about their experiences, discuss treatments and how they have adapted to the pandemic, as well as to provide emotional support.18 It is clear that evidence-based consensus guidelines are needed to decrease the risk of transmission as well as future outbreaks, and social media may have the potential to bring individuals together to create these guidelines. Furthermore, in an international effort to increase access and collaboration and to accelerate COVID-19–related discoveries, many journals, including Ophthalmology (https://www.aaojournal.org/covid-19), have made their COVID-19 related articles freely accessible.
Enabling Preparedness among Ophthalmologists
As COVID-19 spread globally, countries such as China and Italy were affected before the United States, and within the United States, certain states experienced outbreaks earlier than others. This pattern of regional spread enabled lesser-affected areas to prepare for a potential surge of cases. On a national and international level, social media accounts from authorities such as the United States Centers for Disease Control and Prevention, the National Institutes of Health, and World Health Organization used social media campaigns to encourage physical distancing and hand hygiene. The Centers for Disease Control and Prevention has a COVID-19 social media toolkit that provides templated text and images for each social media platform.19 Specific to ophthalmology, designs of shields for slit-lamp biomicroscopes and imaging instrumentation were shared online for use by clinical practices and were circulated on social media.20 , 21 Weeks before large outbreaks in the United States, a report from Asia published in mid-February 2020 suggested the possibility of ophthalmic manifestations of COVID-19 and transmissibility of severe acute respiratory disease coronavirus 2 (SARS-CoV-2) via tears and discussed the importance of protective eyewear.21 Subsequent to this, experience on infection control in Hong Kong eye clinics was published in the first week of March 202020 and later from ophthalmic practices in Singapore22 , 23 and Italy.24 In addition to discussing infection control measures, several studies evaluated the potential transmissibility of SARS-CoV-2 in ocular fluid that were shared widely on social media.25, 26, 27, 28 These early experiences helped to guide ophthalmologists to develop best practices in maximizing the safety for patients, staff, and physicians.15 Furthermore, to provide a central repository and easily accessible source of information, the AAO has created guidelines about SARS-CoV-2 and COVID-19 regarding infection prevention and triage guidance, available at https://www.aao.org/coronavirus. These guidelines are updated regularly. Routinely scheduled Twitter posts from the AAO also update more than 28 000 followers regularly on these evolving guidelines.
Cautions Regarding Social Media during the Pandemic
Because ophthalmologists and healthcare workers in general both seek and share COVID-19–related information on social media, it is important to keep in mind the potential pitfalls of social media. The World Health Organization has cautioned that there has been an overabundance of information during the COVID-19 pandemic, terming it an infodemic.29 Subsequently, this may have resulted in difficulty in finding reliable information. Moreover, misinformation may be propagated via social media.29 Therefore, it is important that accurate information be communicated by experts and appropriate authorities. Although social media has the potential for widespread dissemination of information, the content is not moderated. Healthcare workers should exercise caution when interpreting posts and should continue to follow guidelines from trusted sources.
The use of online preprint servers to disseminate research related to COVID-19 and SARS-CoV-2 has increased significantly. In the physical sciences, archives such as arXiv have been in use for nearly 30 years. In the biological sciences, bioRxiv was founded in 2013 and has seen exponential growth. In contrast, the most popular medical research-related server, medRxiv, was launched in only 2019. The aim of these servers is to disseminate information rapidly, to increase collaboration, and to invite feedback before formal peer review and journal publication. During a time when rapid sharing of information and collaboration are needed to facilitate discoveries of new treatments and to further our understanding of this disease, preprint manuscripts have garnered much attention through both traditional media and social media. Preprints have been shared widely on social media and have been subject to comments by the public and research community.30 Unlike the use of preprint information in other disciplines, the use of unvetted information in preprints in medical practice may harm individuals, and thus they should be viewed with caution by the research community and the media because of their unvetted nature. In this regard, social media may lead to amplification of unvetted information, but also may provide comment on the limitations. For example, a recent headline of a preprint reporting that hydroxychloroquine compared with standard-of-care treatment increased mortality in hospitalized veterans with COVID-1931 was amplified by social media and prominent traditional media sources,32 and within hours of the preprint upload, social media commented on the limitations of the study.33 In general, although rapid delivery of new information has many perceived advantages, preprints should be treated with caution until after undergoing formal expert peer review and publication in an academic journal.
Conclusions
As the pandemic continues to evolve, social media will be an important avenue for physicians to share experiences, to collaborate on research, and to initiate discussion on a global scale. Further study into how social media platforms can be integrated into pandemic preparedness and response will be critical. Freely accessible, peer-reviewed, high-quality evidence from trusted sources also will help to combat widespread misinformation. Undoubtedly, the lessons learned from this pandemic will prepare us better for inevitable future outbreaks.
Footnotes
Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Drs. Tsui, Rao, Carey, Feng, and Provencher are Ophthalmology social media editors.
Supported by an unrestricted grant from Research to Prevent Blindness, Inc., New York, New York (to the Department of Ophthalmology at UCLA [E.T.]); the Beatrice & Reymont Paul Foundation (R.C.R.); March Hoops to Beat Blindness (R.C.R.); the Taubman Institute (R.C.R.); the Leonard G. Miller Endowed Professorship and Ophthalmic Research Fund at the Kellogg Eye Center (R.C.R.); and the Grossman, Elaine Sandman, Marek and Maria Spatz (endowed), Greenspon, Dunn, Avers, Boustikakis, Sweiden, and Terauchi research funds (R.C.R.).
References
- 1.World Health Organization Novel coronavirus (2019-nCoV) situation report—13. 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200511-covid-19-sitrep-112.pdf?sfvrsn=813f2669_2 Accessed 11.05.20.
- 2.Parrish R.K., Stewart M.W., Duncan Powers S.L. Ophthalmologists are more than eye doctors. In memoriam Li Wenliang. Am J Ophthalmol. 2020;213:A1–A2. [Google Scholar]
- 3.Hegarty S. The Chinese doctor who tried to warn others about coronavirus. BBC News. February. 2020;6 https://www.bbc.com/news/world-asia-china-51364382 Accessed 20.05.20. [Google Scholar]
- 4.Kuo I.C., O’Brien T.P. COVID-19 and ophthalmology: an underappreciated occupational hazard. Infect Control Hosp Epidemiol. 2020:1–9. doi: 10.1017/ice.2020.238. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Qiao C, Zhang H, He M, et al. Symptomatic COVID-19 in eye professionals in Wuhan, China. Ophthalmology. 2020; Apr 18;S0161-6420(20)30403-6. https://doi.org/10.1016/j.ophtha.2020.04.026. Online ahead of print. [DOI] [PMC free article] [PubMed]
- 6.Statista Number of social network users worldwide from 2010 to 2023. https://www.statista.com/statistics/278414/number-of-worldwide-social-network-users Accessed 03.05.20.
- 7.Olivia Li J.-P., Shantha J., Wong T.Y. Preparedness among ophthalmologists: during and beyond the COVID-19 pandemic. Ophthalmology. 2020;127:569–572. doi: 10.1016/j.ophtha.2020.03.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Chan T.M., Dzara K., Dimeo S.P. Social media in knowledge translation and education for physicians and trainees: a scoping review. Perspect Med Educ. 2020;9:20–30. doi: 10.1007/s40037-019-00542-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Tsui E., Rao R.C. Navigating social media in #ophthalmology. Ophthalmology. 2019;126:779–782. doi: 10.1016/j.ophtha.2019.02.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Twitter Q1 2020 letter to shareholders. https://investor.twitterinc.com/files/doc_financials/2020/q1/Q1-2020-Shareholder-Letter.pdf Accessed 01.05.20.
- 11.Resnikoff S., Lansingh V.C., Washburn L. Estimated number of ophthalmologists worldwide (International Council of Ophthalmology update): will we meet the needs? Br J Ophthalmol. 2020;104:588–592. doi: 10.1136/bjophthalmol-2019-314336. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Simcock R., Thomas T.V., Estes C. COVID-19: global radiation oncology’s targeted response for pandemic preparedness. Clin Transl Radiat Oncol. 2020;22:55–68. doi: 10.1016/j.ctro.2020.03.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Robinson P.C., Yazdany J. The COVID-19 global rheumatology alliance: collecting data in a pandemic. Nat Rev Rheumatol. 2020;16(6):293–294. doi: 10.1038/s41584-020-0418-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Bilal M., Simons M., Rahman A.U. What constitutes urgent endoscopy? A social media snapshot of gastroenterologists’ views during the COVID-19 pandemic. Endosc Int Open. 2020;8:E693–E698. doi: 10.1055/a-1153-9014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Seitzman G.D., Doan T. No time for tears. Ophthalmology. 2020;127:980–981. doi: 10.1016/j.ophtha.2020.03.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Skalet A.H., Allen R.C., Shields C.L. Considerations for the management and triage of ocular oncology cases during the COVID-19 pandemic. Ocul Oncol Pathol. 2020;6:1–4. doi: 10.1159/000507734. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.American Society of Retina Specialists American Society of Retina Specialists (ASRS) member alert regarding the COVID-19 pandemic. https://www.asrs.org/practice/asrs-member-alert-regarding-covid-19-pandemic Accessed 03.05.20.
- 18.How doctors are using social media to develop coronavirus treatments in real time. Smith M., Cortez M.F., Bloomberg, editors. Fortune. March 24, 2020 https://fortune.com/2020/03/24/doctors-social-media-develop-coronavirus-treatments/ Accessed 21.05.20. [Google Scholar]
- 19.United States Centers for Disease Control and Prevention Social media toolkit. https://www.cdc.gov/coronavirus/2019-ncov/communication/social-media-toolkit.html Accessed 11.05.20.
- 20.Lai T.H.T., Tang E.W.H., Chau S.K.Y. Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong. Graefes Arch Clin Exp Ophthalmol. 2020;258:1049–1055. doi: 10.1007/s00417-020-04641-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Wong D.H.T., Mak S.T., Yip N.K.F., Li K.K.W. Protective shields for ophthalmic equipment to minimise droplet transmission of COVID-19. Graefes Arch Clin Exp Ophthalmol. 2020;258(7):1571–1573. doi: 10.1007/s00417-020-04683-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Jun I.S.Y., Hui K.K.O., Songbo P.Z. Perspectives on coronavirus disease 2019 control measures for ophthalmology clinics based on a Singapore center experience. JAMA Ophthalmol. 2020; Mar 31 doi: 10.1001/jamaophthalmol.2020.1288. Online ahead of print. [DOI] [PubMed] [Google Scholar]
- 23.Lim L.W., Yip L.W., Tay H.W. Sustainable practice of ophthalmology during COVID-19: challenges and solutions. Graefes Arch Clin Exp Ophthalmol. 2020;258(7):1427–1436. doi: 10.1007/s00417-020-04682-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Romano M.R., Montericcio A., Montalbano C. Facing COVID-19 in ophthalmology department. Curr Eye Res. 2020;45(6):653–658. doi: 10.1080/02713683.2020.1752737. [DOI] [PubMed] [Google Scholar]
- 25.Zhou Y., Duan C., Zeng Y. Ocular findings and proportion with conjunctival SARS-CoV-2 in COVID-19 patients. Ophthalmology. 2020;127:982–983. doi: 10.1016/j.ophtha.2020.04.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Seah I.Y.J., Anderson D.E., Kang A.E.Z. Assessing viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients. Ophthalmology. 2020;127:977–979. doi: 10.1016/j.ophtha.2020.03.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Wu P., Duan F., Luo C. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138(5):575–578. doi: 10.1001/jamaophthalmol.2020.1291. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.@AAOjournal (Ophthalmology) New #COVID-19 study from Singapore suggests the risk of #ocular transmission is low, with no evidence of viral shedding detected in tears through the course of the disease. https://twitter.com/AAOjournal/status/1242782304885448704 Accessed May 8, 2020.
- 29.World Health Organization Novel coronavirus (2019-nCoV) situation report—13. 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200202-sitrep-13-ncov-v3.pdf Accessed 01.05.20.
- 30.The Economist Scientific research on the coronavirus is being released in a torrent. May 7, 2020. https://www.economist.com/science-and-technology/2020/05/07/scientific-research-on-the-coronavirus-is-being-released-in-a-torrent Accessed 09.05.20.
- 31.Magagnoli J., Nardendran S., Pereira F. Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19. medrxivorg. https://www.medrxiv.org/content/10.1101/2020.04.16.20065920v1.full.pdf Accessed 11.05.20. [DOI] [PMC free article] [PubMed]
- 32.Cohen E., Nigam M. Study finds no benefit, higher death rate in patients taking hydroxychloroquine for Covid-19. CNN. April 21, 2020 https://www.cnn.com/2020/04/21/health/hydroxychloroquine-veterans-study/index.html Available at. Accessed 08.05.20. [Google Scholar]
- 33.@CMichaelGibson (C. Michael Gibson, MD). Sanjay Gupta reviewing VA “study” on #hydroxychloroquine says no benefit of HCQ & 2X as many people died. Fails to mention that it is not a randomized study & that the differences could be due to confounding (sicker people got HCQ). We must do better in communicating science. April 21, 2020. https://twitter.com/CMichaelGibson/status/1252669480334962690; Accessed May 8, 2020.